Trial Profile

Exploratory Study to Evaluate Safety, Mechanistic and Clinical Effects of MH002 in Subjects with Acute Pouchitis

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 03 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MH 002 (Primary)
Indications Pouchitis
Focus Adverse reactions
Sponsors MRM Health

Most Recent Events

16 Apr 2024 Positive safety and efficacy results presented in a MRM Health Media Release.
07 Mar 2023 According to a MRM Health media release, company announced, initial data from this trial will be available in Q4 2023
07 Mar 2023 Status changed to recruiting, according to a MRM Health media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com